Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE) Article

publication date

May 20, 2022

webpage

Web of Science

published in

DERMATOLOGY AND THERAPY Journal

keywords

Atopic dermatitis
Baseline
Dupilumab
Eczema
Registry